Coronet Ventures is the Singapore-based venture entity of Cedars-Sinai Intellectual Property (CSIP) Co, identifying and investing in early-stage healthcare and biomedical science startups in the region. The first international investment operation for CSIP, Coronet Ventures is focused on solutions that are directed to the US market and synergistic with Cedars-Sinai Medical Center’s areas of excellence.
Our mission is to improve the quality of life for patients around the world through our investments in healthcare and biomedical companies. The startups we support will further advance Cedars-Sinai’s mission of delivering quality healthcare services, as well as CSIP’s mission of intellectual property development and commercialization.
Expanding Cedars-Sinai’s reputation as an academic innovation leader, Coronet Ventures will provide its companies with access to key opinion leaders, partners, data, clinical trials, and collaborations with the strategic programs of Cedars-Sinai. We are looking for “first-in-class and best-in-class” solutions across segments such as diagnostics, pharmaceuticals, medical devices, and digital health.